Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Jajco, Inc. DBA Anchor Drugs Pharmacy
483
•Jajco, Inc. DBA Anchor Drugs Pharmacy•October 29, 2018

Jajco, Inc. DBA Anchor Drugs Pharmacy – FDA 483, Oct 29, 2018

Record Details

During an inspection conducted by the U.S. Food and Drug Administration (FDA) from October 24 to October 29, 2018, Jajco, Inc. operating as Anchor Drugs Pharmacy, a producer of non-sterile drug products, received a Form FDA 483. This document outlined significant observations regarding the firm’s manufacturing practices, indicating deviations from expected quality standards. The primary concerns revolved around inadequate cleaning procedures and contamination control. Specifically, the FDA noted that Jajco, Inc. produced hazardous drugs, such as testosterone and estradiol, without ensuring proper cleaning of work surfaces and utensils. The firm utilized non-dedicated equipment cleaned with common household detergents and wipes, a process deemed insufficient to prevent potential cross-contamination between different drug substances. This poses a risk to patient safety by potentially mixing active pharmaceutical ingredients. Furthermore, investigators observed non-microbial contamination, characterized by powder residue buildup, in a production hood used for compounding various non-sterile human, animal, and hazardous drugs. Critical areas within this equipment were not included in the firm's routine cleaning operations, exacerbating the risk of product contamination. The FDA 483 signifies that Jajco, Inc. must promptly address these deficiencies by developing and implementing comprehensive corrective and preventive actions. These actions are crucial to ensure compliance with good manufacturing practices, safeguard product quality, and prevent adulteration of drug products.

Company
Jajco, Inc. DBA Anchor Drugs Pharmacy
Inspection date
October 29, 2018
Product type
Drugs
Office
San Francisco District Office
People
  • Farhana Khan (Food and Nutration Service )
  • Ashar P. Parikh
View Company Profile

ID · 0c1eff89-e264-403a-b3fc-ef744e4edf6e

Other documents for Jajco, Inc. DBA Anchor Drugs Pharmacy
  • STATE_REFERRAL_LETTER - 2018-10-24October 24, 2018
  • WARNING_LETTER - 2016-06-03June 3, 2016
  • 483 - 2016-06-03June 3, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jajco, Inc. DBA Anchor Drugs Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.